Fed. Circ. Revives Generic Benicar Exclusivity Challenge
In a precedential opinion, the Federal Circuit on Tuesday revived a suit by Apotex Inc. that sought a judgment that its generic version of Daiichi Sankyo Inc.'s hypertension drug Benicar will...To view the full article, register now.
Already a subscriber? Click here to view full article